Carolyn Helms is Managing Director and Chief Financial Officer at Longitude Capital. Longitude Capital invests in biotechnology, medical technology, and health solutions across the United States, including California, Massachusetts, New England, and Connecticut, at stages spanning seed, Series B/C, growth equity, and clinical- and commercial-stage opportunities. The firm raised $135 million in July 2021. Its investments include companies such as 89bio, Axonics Modulation Technologies, Ceribell, Mirum Pharmaceuticals, and Vaxcyte. Before her current role, she served as Chief Financial Officer and Chief Compliance Officer, VP of Finance and Chief Compliance Officer, and Director of Finance at Longitude Capital; earlier in her career she was Controller at Sierra Ventures, Accounting Manager at Net Manage Inc, and a Senior Auditor at Arthur Andersen & Co. Carolyn graduated from San José State University and resides in the San Francisco Bay Area.
Carolyn Helms, Managing Director @ Longitude. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Carolyn Helms from Longitude Capital. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Carolyn
Map your path to Carolyn instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Carolyn
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.